GB202100648D0 - Polypeptide - Google Patents

Polypeptide

Info

Publication number
GB202100648D0
GB202100648D0 GBGB2100648.1A GB202100648A GB202100648D0 GB 202100648 D0 GB202100648 D0 GB 202100648D0 GB 202100648 A GB202100648 A GB 202100648A GB 202100648 D0 GB202100648 D0 GB 202100648D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2100648.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Freeline Therapeutics Ltd
Original Assignee
Freeline Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freeline Therapeutics Ltd filed Critical Freeline Therapeutics Ltd
Priority to GBGB2100648.1A priority Critical patent/GB202100648D0/en
Publication of GB202100648D0 publication Critical patent/GB202100648D0/en
Priority to MX2023001137A priority patent/MX2023001137A/en
Priority to IL299811A priority patent/IL299811A/en
Priority to CN202180066422.7A priority patent/CN116322744A/en
Priority to KR1020237007296A priority patent/KR20230042513A/en
Priority to CA3189801A priority patent/CA3189801A1/en
Priority to PCT/GB2021/051969 priority patent/WO2022023761A2/en
Priority to JP2023506111A priority patent/JP2023535808A/en
Priority to EP21752123.6A priority patent/EP4118200A2/en
Priority to BR112023001583A priority patent/BR112023001583A2/en
Priority to US18/017,158 priority patent/US20240261433A1/en
Priority to AU2021316875A priority patent/AU2021316875A1/en
Ceased legal-status Critical Current

Links

GBGB2100648.1A 2020-07-29 2021-01-18 Polypeptide Ceased GB202100648D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB2100648.1A GB202100648D0 (en) 2021-01-18 2021-01-18 Polypeptide
AU2021316875A AU2021316875A1 (en) 2020-07-29 2021-07-29 Mutated beta-glucocerebrosidase with improved stability
KR1020237007296A KR20230042513A (en) 2020-07-29 2021-07-29 polypeptide
IL299811A IL299811A (en) 2020-07-29 2021-07-29 Polypeptide
CN202180066422.7A CN116322744A (en) 2020-07-29 2021-07-29 Mutant beta-glucocerebrosidase with improved stability
MX2023001137A MX2023001137A (en) 2020-07-29 2021-07-29 Mutated beta-glucocerebrosidase with improved stability.
CA3189801A CA3189801A1 (en) 2020-07-29 2021-07-29 Polypeptide
PCT/GB2021/051969 WO2022023761A2 (en) 2020-07-29 2021-07-29 Polypeptide
JP2023506111A JP2023535808A (en) 2020-07-29 2021-07-29 Mutant beta-glucocerebrosidase with improved stability
EP21752123.6A EP4118200A2 (en) 2020-07-29 2021-07-29 Mutated beta-glucocerebrosidase with improved stability
BR112023001583A BR112023001583A2 (en) 2020-07-29 2021-07-29 MODIFIED SS-GLUCOCEREBROSIDASE (GCASE) POLYPEPTIDES, POLYNUCLEOTIDE, VIRAL PARTICLE AND COMPOSITION
US18/017,158 US20240261433A1 (en) 2020-07-29 2021-07-29 Polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2100648.1A GB202100648D0 (en) 2021-01-18 2021-01-18 Polypeptide

Publications (1)

Publication Number Publication Date
GB202100648D0 true GB202100648D0 (en) 2021-03-03

Family

ID=74678915

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2100648.1A Ceased GB202100648D0 (en) 2020-07-29 2021-01-18 Polypeptide

Country Status (1)

Country Link
GB (1) GB202100648D0 (en)

Similar Documents

Publication Publication Date Title
GB202017649D0 (en) Polypeptide
GB202007441D0 (en) Polypeptide
IL288412A (en) Peptides
IL289122A (en) Polypeptides
IL289119A (en) Polypeptides
GB202007532D0 (en) Polypeptides
EP4172173A4 (en) Neutrophil-binding peptides
IL299811A (en) Polypeptide
GB202019879D0 (en) Polypeptide
IL308465A (en) Sars-cov-2 polypeptides
GB201810052D0 (en) Polypeptide
IL311448A (en) Polypeptide
GB202119034D0 (en) Polypeptide
GB202105924D0 (en) Polypeptide
GB202103001D0 (en) Polypeptide
GB202100648D0 (en) Polypeptide
GB202013372D0 (en) Polypeptide
GB202011813D0 (en) Polypeptide
GB202005333D0 (en) Polypeptide
GB202319601D0 (en) Polypeptide
GB202102598D0 (en) An isolated polypeptide
GB202111640D0 (en) Polypeptides
GB202113858D0 (en) Peptides
GB202110693D0 (en) Peptides
IL311773A (en) Peptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)